Novus Biologicals products are now on bio-techne.com

Human FABP2/I-FABP DuoSet ELISA, 15 Plate

Images

 

Product Details

Summary
Reactivity HuSpecies Glossary
Applications ELISA
Conjugate
Biotin

Order Details

Novus Biologicals is part of Bio-Techne

Shop this product on bio-techne.com

Human FABP2/I-FABP DuoSet ELISA, 15 Plate Summary

Source
N/A
Assay Type
Solid Phase Sandwich ELISA
Inter-Assay
See PDF Datasheet for details
Intra-Assay
See PDF Datasheet for details
Spike Recovery
See PDF Datasheet for details
Sample Volume
See PDF Datasheet for details
Gene
FABP2

Applications/Dilutions

Dilutions
  • ELISA
Application Notes
No significant interference observed with available related molecules.
Publications
Read Publications using DY3078.

Packaging, Storage & Formulations

Storage
Store the unopened product at 2 - 8 °C. Do not use past expiration date.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Human FABP2/I-FABP DuoSet ELISA, 15 Plate

  • FABP2
  • FABPI
  • fatty acid binding protein 2, intestinal
  • Fatty acid-binding protein 2
  • fatty acid-binding protein, intestinal
  • IFABP
  • I-FABP
  • I-FABPMGC133132
  • Intestinal FABP
  • Intestinal-type fatty acid-binding protein

Background

Fatty acid binding proteins are small cytoplasmic lipid binding proteins that are expressed in a tissue specific manner. FABPs bind free fatty acids, cholesterol, and retinoids, and are involved in intracellular lipid transport. Circulating FABP levels are used as indicators of tissue damage. Some FABP polymorphisms have been associated with disorders of lipid metabolism and the development of atherosclerosis.

FABP2, also known as intestinal fatty acid binding protein (I-FABP or FABPI) and gut FABP (gFABP), is a member of the cytosolic fatty acid binding protein family. FABP2 mediates the absorption and intracellular transport of dietary long-chain fatty acids. Genetic variations of FABP2 are implicated in obesity and Type II diabetes. Human FABP2 shares 78%, 82%, and 86% amino acid sequence identity with mouse, rat, and canine FABP2, respectively.

Customers Who Viewed This Item Also Viewed...

AF3166
Species: Hu
Applications: IHC, Simple Western, WB
NBP1-87695
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, IHC-P, WB
MAB1417
Species: Bv, Hu, Mu
Applications: CyTOF-ready, ICC, IHC, ICFlow
AF1476
Species: Hu, Mu, Rt
Applications: IHC, KO, Simple Western, WB
MAB1678
Species: Hu, Mu, Rt
Applications: IHC, Simple Western, WB
AF3880
Species: Hu
Applications: ICC, WB
DY1707
Species: Hu
Applications: ELISA
DLP00
Species: Hu
Applications: ELISA
NB100-2564
Species: Hu
Applications: WB
NBP2-01743
Species: Hu
Applications: Flow, ICC/IF, IHC, IHC-P, WB
NBP2-22106
Species: Hu, Mu, Rt
Applications: IHC, IHC-P, IP, WB
NB600-610
Species: Bv, Hu
Applications: ELISA, ICC/IF, IHC, IHC-P, IP, WB
NBP2-34294
Species: Hu, Mu, Rt
Applications: Flow, IHC, IHC-P
NBP1-62489
Species: Dr, Hu, Mu
Applications: WB
AF1443
Species: Mu, Rt
Applications: ICC, IHC, Simple Western, WB
AF7197
Species: Hu, Mu
Applications: ICC, IHC, WB
NB300-537
Species: Bv, Hu, Mu, Rb, Rt
Applications: ChIP, Flow, GS, ICC/IF, IHC, IHC-P, IP, KD, WB
DY3078
Species: Hu
Applications: ELISA

Publications for FABP2/I-FABP (DY3078)(28)

We have publications tested in 2 confirmed species: Human, Primate - Macaca mulatta (Rhesus Macaque).


Filter By Application
All Applications
Filter By Species
Human
(27)
Primate - Macaca mulatta (Rhesus Macaque)
(1)
All Species
Showing Publications 1 - 10 of 28. Show All 28 Publications.
Publications using DY3078 Applications Species
Boby, N;Williams, KM;Das, A;Pahar, B; Toll-like Receptor 2 Mediated Immune Regulation in Simian Immunodeficiency Virus-Infected Rhesus Macaques Vaccines 2023-12-17 [PMID: 38140264] (Primate - Macaca mulatta (Rhesus Macaque)) Primate - Macaca mulatta (Rhesus Macaque)
Sereti, I;Verburgh, ML;Gifford, J;Lo, A;Boyd, A;Verheij, E;Verhoeven, A;Wit, FWNM;Schim van der Loeff, MF;Giera, M;Kootstra, NA;Reiss, P;Vujkovic-Cvijin, I; Impaired gut microbiota-mediated short-chain fatty acid production precedes morbidity and mortality in people with HIV Cell reports 2023-10-30 [PMID: 37918403] (Human) Human
Höpfinger, A;Karrasch, T;Schäffler, A;Schmid, A; Circulating Concentrations of Cathelicidin Anti-Microbial Peptide (CAMP) Are Increased during Oral Glucose Tolerance Test International journal of molecular sciences 2023-08-17 [PMID: 37629082] (Human) Human
Höpfinger, A;Karrasch, T;Schäffler, A;Schmid, A; Circulating Levels of Cathelicidin Antimicrobial Peptide (CAMP) Are Affected by Oral Lipid Ingestion Nutrients 2023-07-03 [PMID: 37447348] (Human) Human
Coufal, S;Kverka, M;Kreisinger, J;Thon, T;Rob, F;Kolar, M;Reiss, Z;Schierova, D;Kostovcikova, K;Roubalova, R;Bajer, L;Jackova, Z;Mihula, M;Drastich, P;Tresnak Hercogova, J;Novakova, M;Vasatko, M;Lukas, M;Tlaskalova-Hogenova, H;Jiraskova Zakostelska, Z; Serum TGF-?1 and CD14 Predicts Response to Anti-TNF-? Therapy in IBD Journal of immunology research 2023-06-20 [PMID: 37383609] (Human) Human
DL Tahapary, AI Fatya, F Kurniawan, C Marcella, I Rinaldi, TJE Tarigan, DS Harbuwono, E Yunir, P Soewondo, D Purnamasar Increased intestinal-fatty acid binding protein in obesity-associated type 2 diabetes mellitus PLoS ONE, 2023-01-26;18(1):e0279915. 2023-01-26 [PMID: 36701395] (Human) Human
L Blöbaum, M Witkowski, M Wegner, S Lammel, PA Schencke, K Jakobs, M Puccini, D Rei beta ner, D Steffens, U Landmesser, U Rauch, J Friebel Intestinal Barrier Dysfunction and Microbial Translocation in Patients with First-Diagnosed Atrial Fibrillation Biomedicines, 2023-01-10;11(1):. 2023-01-10 [PMID: 36672684] (Human) Human
J Araújo Fiu, S Colt, L Gambogi de, L Ferreira M, A Gazzinelli, JF Friedman, R Corrêa-Oli The role of environmental enteric dysfunction in the pathogenesis of Schistosoma mansoni-associated morbidity in school-aged children PloS Neglected Tropical Diseases, 2022-10-05;16(10):e0010837. 2022-10-05 [PMID: 36197916] (Human) Human
ML Sarangam, R Namazzi, D Datta, C Bond, CPB Vanderpool, RO Opoka, CC John, AL Conroy Intestinal Injury Biomarkers Predict Mortality in Pediatric Severe Malaria MBio, 2022-09-07;0(0):e0132522. 2022-09-07 [PMID: 36069443] (Human) Human
AI Amaruddin, JPR Koopman, M Muhammad, K Lenaerts, HMH van Eijk, EAT Brienen, AR Geelen, L van Liesho, S Wahyuni, EJ Kuijper, RD Zwittink, F Hamid, E Sartono, M Yazdanbakh Intestinal permeability before and after albendazole treatment in low and high socioeconomic status schoolchildren in Makassar, Indonesia Scientific Reports, 2022-03-01;12(1):3394. 2022-03-01 [PMID: 35233023] (Human) Human
Show All 28 Publications.

Reviews for FABP2/I-FABP (DY3078) (0)

There are no reviews for FABP2/I-FABP (DY3078). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

Product General Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs for FABP2/I-FABP (DY3078) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Additional FABP2/I-FABP Products

Blogs on FABP2/I-FABP

There are no specific blogs for FABP2/I-FABP, but you can read our latest blog posts.
Read our latest blog and use the new citation tool on bio-techne.com

Customers Who Bought This Also Bought

Contact Information

Product PDFs

Review this Product

Be the first to review our Human FABP2/I-FABP DuoSet ELISA, 15 Plate and receive a gift card or discount.

Bioinformatics

Gene Symbol FABP2